Best in Biotech 28 Jan 2026 Seven Italian biotechs to know about in 2026 Delve into Italy’s biotech landscape with seven companies that are leading the charge in the European country. January 28, 2026 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 23 Jan 2026 What does 2026 hold for the biotech industry? Delve into what 2026 has to offer in the biotech industry. The market is showing signs it’s picking up and the patent cliff is driving deals. January 23, 2026 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Jan 2026 Curing ALS? Ten companies developing new treatments in 2026 Delve into the increasingly dynamic landscape of ALS treatment development with ten companies advancing candidates in 2026. January 19, 2026 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 14 Jan 2026 The AbbVie strategy, a company at an inflection point Look into AbbVie’s strategy a company built around its blockbuster Humira, now diversifying its pipeline after the patent cliff. January 14, 2026 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 13 Jan 2026 Seven biotech companies to know in the Netherlands Explore some of the top biotech companies in the Netherlands, which has established itself as a burgeoning biotech and life sciences hub. January 13, 2026 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jan 2026 Can the thymus be drugged? TECregen raises $12 million to find out Find out about TECregen’s, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics.” January 8, 2026 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 26 Dec 2025 When biotech makes Christmas miracles happen — second edition As 2025 comes to a close, delve into some biotech feel-good stories where the right treatment meets the right patient, almost feeling like a miracle. December 26, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 16 Dec 2025 Biotech in 2025: A retrospective Take a look back into biotech in 2025 as the year is closing – from GLP-1s to radiopharmaceuticals and neuroplastogens. December 16, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Dec 2025 Keep an eye on these 15 biotech companies in 2026 Some companies have had wins in 2025, while others have major milestones coming up. Here are 15 biotechs to watch as we head into 2026. December 15, 2025 - 21 minutesmins - Multiple Authors Share WhatsApp Twitter Linkedin Email
In Depth 9 Dec 2025 When AI isn’t enough: How physics is shaping the next wave of drug discovery Discover what the next wave of AI-assisted drug discovery looks like and how it can help biotech – the AI and physics combo. December 9, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 2 Dec 2025 Vandria reports VNA-318’s first-in-human data in Alzheimer’s Delve into Vandria’s technology and its Alzheimer’s candidate, VNA-318, the first mitophagy-based candidate in Alzheimer’s to reach the clinic. December 2, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 1 Dec 2025 Stem cell therapy’s avant-garde: Eight companies leading the way Stem cell therapy has gained traction over the recent years and the market is growing, discover eight companies advancing the field. December 1, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email